Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study is testing a new injectable drug called SYH2053 to see if it safely lowers 'bad' cholesterol (LDL-C) in adults with high cholesterol or mixed lipid problems. It will compare the drug against a placebo (dummy injection) in 760 participants over about a year. The main go…

This study is testing a new injectable drug called SYH2053 for people with high cholesterol that isn't well controlled by their current medications. It will enroll 900 adults to see if the injection safely lowers 'bad' LDL cholesterol more effectively than a placebo shot. The goa…

This study is testing an investigational injection called SYH2053 to see if it can effectively lower 'bad' cholesterol in adults with a genetic condition that causes very high cholesterol levels (HeFH). About 135 participants will receive either the injection or a placebo, in add…

This is the first study in people for a new drug called SYH2061. It will test the drug's safety and how the body handles it in 40 healthy volunteers. Researchers will give increasing single doses to different groups and compare results to a placebo. The main goal is to see if the…